November 24, 2025

Oral PCSK9 Inhibitor Tied to LDL-C Drop

The oral PCSK9 inhibitor enlicitide decanoate achieved 58% LDL-C reduction in patients with heterozygous familial hypercholesterolemia, offering a potential alternative to injectable therapies.

Conexiant

November 21, 2025

ALD-related HCC mortality surges 

 The findings underscore the urgent need for targeted prevention strategies among high-risk group.

Conexiant

November 21, 2025

Tirzepatide tops semaglutide for cardiometabolic protection in MASLD

The study authors recommend prospective head-to-head trials to validate the findings.

Conexiant

November 21, 2025

Positive trends in chronic HCV mortality 

“DAAs have revolutionized the management of HCV by making it a curable disease.”

Conexiant

November 20, 2025

New score challenges old predictors

"MERAGE has superior performance for predicting return to drinking (RTD) compared to HRAR in AH."

Conexiant

November 15, 2025

AI Models Predict CNS Tumors From Spinal Fluid

At AMP 2025, a South Korean research team outlined a multimodal approach that integrates CSF, DNA, and MRI data to enable early, noninvasive tumor classification.

Conexiant

November 14, 2025

New ddPCR Test Detects Lyme Disease More Accurately

The droplet digital PCR assays, developed at Dartmouth, could improve diagnosis of Lyme disease.

Conexiant

November 14, 2025

Streamlining VUS Classification in Clinical Genomics

New variant classification standards and data-sharing initiatives will help laboratories and clinicians focus on actionable variants.

Conexiant

November 14, 2025

RNA Testing Uncovers Hidden Gene Fusions in AML

Michigan team finds cryptic leukemia-defining rearrangements missed by standard cytogenetics.

Conexiant